MENS Stock: Jyong Biotech Ltd. Ordinary Shares Stock Price, Analysis & Insights
Get live mens stock price $2.92, comprehensive Jyong Biotech Ltd. Ordinary Shares stock analysis, charts, news, and expert forecast. Real-time mens stock data and investment insights.
Loading chart...
Company Overview
Jyong Biotech Ltd. is a Taiwan-based biotech firm focused on developing and commercializing plant-derived drugs targeting urinary system diseases. The company operates through its subsidiaries—Health Ever Bio-Tech, Genvace, and others—working on drug candidates like MCS‑2 (for BPH) currently in Phase III, PCP (for prostate cancer) in Phase II, and IC in pre-clinical stages
Company Information
- CEO
- Fu-Feng Kuo
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 31
Contact Information
- Website
- https://www.jyongbio.com/
- Address
- 23F‑3, No. 95, Section 1, Xintai 5th Road
- Country
- TW
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 6.19)
Business Model & Strategy
Jyong Biotech Ltd. Ordinary Shares operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Fu-Feng Kuo, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Jyong Biotech Ltd. Ordinary Shares competes in the Biotechnology within the broader Healthcare. With 222.0 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Select, Jyong Biotech Ltd. Ordinary Shares provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Jyong Biotech Ltd. Ordinary Shares should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Jyong Biotech Ltd. Ordinary Shares shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Jyong Biotech Ltd. Ordinary Shares
- ⚠Investors should consider how Jyong Biotech Ltd. Ordinary Shares fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
222.00M
P/E Ratio
-73.00
Beta
6.19
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 222.00M market capitalization
- Trading Volume: 3.15M shares traded today
- Price Range: 52-week range of $2.81 - $67.00
- Exchange: Listed on NASDAQ Global Select
Financial Metrics
Market Analysis for Jyong Biotech Ltd. Ordinary Shares
Jyong Biotech Ltd. Ordinary Shares (MENS) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 222.00M, the company represents a significant player in its market. The stock is currently trading at $2.92 with a negativedaily change of 81.04%.
The company's 31 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -73.00, beta of 6.19, and 52-week price range from $2.81 to $67.00when evaluating investment opportunities.
Why Invest in Jyong Biotech Ltd. Ordinary Shares?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Select)
- • Experienced leadership under Fu-Feng Kuo
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.